CoralOghenerukevweOmeneMDPhD
Oncology • New Brunswick, NJBreast Cancer, Hematologic Oncology
Program Director, Breast Cancer Disparities Research; Associate Professor of Medicine; Rutgers Cancer Institute; Division of Medical Oncology; Rutgers, The State University of New Jersey
Dr. Omene is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St.
New Brunswick, NJ 08903Phone+1 732-235-9692Fax+1 732-235-7943
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2006
Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
NJ State Medical License 2017 - 2025
NY State Medical License 2005 - 2017- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases Start of enrollment: 2011 Aug 19
Publications & Presentations
PubMed
- 2 citationsDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01 - 6 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01 - 2 citationsPromoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of...Jinghua An, Jeanne M Ferrante, Myneka Macenat, Shridar Ganesan, Shawna V Hudson
Cancer. 2024-10-15
Grant Support
- Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC)NIH/NCIPresent
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
